What is INSP's current stock price?

INSP (Inspire Medical Systems, Inc.) is currently trading at $43.84 with a market cap of $1.26B.

What sector is Inspire Medical Systems, Inc. in?

Inspire Medical Systems, Inc. (INSP) operates in the Healthcare sector, specifically in the Medical - Devices industry.

Is INSP a good stock to buy?

Analysts have a Hold consensus on INSP with a price target of $67.17. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

INSP Inspire Medical Systems, Inc.

Healthcare

$43.84-2.01%ClosedMarket Cap: $1.26B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

10.70

PEG

0.06

P/B

1.59

P/S

1.38

EV/EBITDA

16.52

DCF Value

$133.86

FCF Yield

7.7%

Div Yield

0.0%

Margins & Returns

Gross Margin

85.8%

Operating Margin

5.6%

Net Margin

14.3%

ROE

18.0%

ROA

14.4%

ROIC

6.2%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$204.6M	$-11.3M	$—
Q4 null	$269.1M	$136.1M	$—
FY null	$912.0M	$145.4M	$—
Q3 null	$224.5M	$9.9M	$—

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$67.17

Target (Median)

$57.50

Target Range

$39.00 - $175.00

1 Strong Buy4 Buy12 Hold0 Sell1 Strong Sell

OppenheimerPerform

2026-05-07

Truist SecuritiesHold

2026-05-05

RBC CapitalSector Perform

2026-05-05

MizuhoOutperform

2026-05-05

Evercore ISI GroupOutperform

2026-05-05

Trading Activity

Insider Trades

View All

Rondoni Johnofficer: See Remarks

SellTue May 19

Rondoni Johnofficer: See Remarks

SellFri May 15

mcCormick Shawndirector

SellMon May 11

Tansey Casey Mdirector

SellMon May 04

Melenikiotou Georgiadirector

SellMon May 04

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

Exchange

—

Beta

0.83

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Peers

BKD